Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and weight management, raising questions about its effects on eye health
What it does offer is hydration, healing, and anti-aging benefits , making it a safe and effective component of modern skincare and joint health routines
Individual response varies, and factors such as side effect tolerance, cost, and availability all play a role in choosing the best option
Outside of the GLP-1 market, due to capacity displacement by GLP-1 products, CDMOs should be ready with capacity to meet non-GLP-1 fill/finish needs
It is made by one of the most popular manufacturers for this product category and there are hundreds of distributors that supply it across supermarkets and markets in Lagos, Nigeria